Robert P Fisher

Robert P Fisher, MD, PhD

  • PROFESSOR | Oncological Sciences
  • PROFESSOR | Pharmacological Sciences

Robert Fisher, MD, PhD, is Professor of Oncological Sciences at the Icahn School of Medicine at Mount Sinai and a member of The Tisch Cancer Institute. Prior to joining Mount Sinai in 2009, Dr. Fisher was with the Molecular Biology Program at Sloan-Kettering Institute and Cornell University Graduate School of Medical Sciences.

Dr. Fisher has more than 25 years of experience studying the central roles of cyclin-dependent kinases (CDKs) in regulating cell division and gene expression. His laboratory has developed powerful chemical-genetic techniques to identify new components, regulators and targets of the CDK network, and has used these tools to define molecular mechanisms coordinating cell division and transcription that had escaped prior detection by standard procedures. Dr. Fisher and his research team are currently developing novel applications of chemical genetics to illuminate new pathways and mechanisms. His most recent R35 grant from the National Institutes of Health supports research on CDK control of cell-division and transcription cycles.

Dr. Fisher has served as Co-Director of the Structural and Chemical Biology and Molecular Design Multidisciplinary Training Area of the Icahn School of Biomedical Sciences at Mount Sinai. He has served as a member of Faculty of 1000 and the Steering Committee of the Chemical Biology Discussion Group of the New York Academy of Sciences. He has been on the editorial boards of EMBO Reports and F1000 Research, and is a frequent peer reviewer for top-tier journals, including Nature, Cell, Science, and eLife, and for national and international funding agencies. Dr. Fisher has also been an ad hoc member of several NIH Study Sections.

Multi-Disciplinary Training Areas

Cancer Biology [CAB], Pharmacology and Therapeutics Discovery [PTD]


MD, Stanford University

PhD, Stanford University